Our Pricing

Understanding Saxenda Pills and Oral Weight Loss Alternatives in the UK

Published: 24 August 2026

Many patients search for saxenda pills hoping to find an oral tablet version of this popular weight loss medication, but it's important to understand that Saxenda (liraglutide) is only available as a daily injection pen in the UK. However, effective oral weight loss alternatives are now available, including Wegovy® Oral Tablets (semaglutide pill) from £48.00 and Orlistat-based treatments from £48.00, all subject to clinical assessment by our UK-registered prescribers at Cured Pharmacy.

Why Saxenda Pills Don't Exist: Understanding Liraglutide Delivery

The search for saxenda pills reflects a common misconception about how liraglutide, the active ingredient in Saxenda, can be delivered. Saxenda is exclusively manufactured as a pre-filled injection pen containing 6mg/ml liraglutide solution, administered subcutaneously once daily [1]. The reason no pill form exists is biochemical: liraglutide is a GLP-1 receptor agonist peptide that would be broken down by stomach acid and digestive enzymes if taken orally, rendering it completely ineffective.

Pharmaceutical companies have invested years developing oral GLP-1 formulations, but these require special absorption enhancers to protect the active ingredient through the digestive system [2]. Saxenda's manufacturer has not created such a formulation for liraglutide in pill form. Patients seeking saxenda pills should instead consider either the original Saxenda injection (from £48.00 at Cured Pharmacy, subject to prescriber approval) or explore genuine oral weight loss alternatives that have been specifically designed for tablet delivery.

Oral Alternatives to Saxenda Pills: Wegovy® Tablets and Orlistat

For patients specifically seeking saxenda pills in oral form, two evidence-based alternatives are available through Cured Pharmacy. Wegovy® Oral Tablets contain semaglutide, a next-generation GLP-1 receptor agonist chemically similar to liraglutide but formulated with a proprietary absorption enhancer (SNAC) that enables oral delivery [3]. Clinical trials showed patients taking oral semaglutide achieved average weight loss of 15.1% over 68 weeks, comparable to injection-based GLP-1 treatments.

Orlistat represents a completely different mechanism: rather than affecting appetite hormones like saxenda pills would, it blocks approximately 30% of dietary fat absorption in the intestines [4]. Available as Orlistat 120mg (from £48.00), Xenical (from £48.00), and lower-dose Alli 60mg or Orlos 60mg (from £48.00), these oral capsules are taken three times daily with meals. While less dramatic than GLP-1 treatments, Orlistat produces average weight loss of 5-10% when combined with calorie reduction and has been licensed in the UK for over two decades.

How Oral Semaglutide Tablets Work

Wegovy® Oral Tablets solve the digestive breakdown problem that prevents saxenda pills from existing. Each tablet contains semaglutide co-formulated with salcaprozate sodium (SNAC), an absorption enhancer that temporarily raises stomach pH and facilitates peptide absorption across the gastric lining [5]. Patients take one tablet daily on an empty stomach with no more than 120ml water, then wait 30 minutes before eating or drinking. This strict administration protocol is essential for absorption — unlike a hypothetical saxenda pill, timing matters significantly with oral semaglutide.

Saxenda Pills Pricing Comparison: What Oral Treatments Actually Cost

While saxenda pills don't exist, understanding the cost of genuine oral alternatives helps patients make informed decisions. At Cured Pharmacy, Wegovy® Oral Tablets start from £48.00 per month supply, Orlistat 120mg from £48.00 for 84 capsules (28-day supply), and Xenical branded Orlistat from £48.00. All prices are transparent and displayed before your free online consultation, with £20 off your first order using code Weightlossnew.

For comparison, the injectable Saxenda that patients search for as saxenda pills costs from £48.00 per pen at Cured Pharmacy, with each pen providing approximately 6 days of treatment at the maximum 3.0mg maintenance dose. Treatment choice depends on individual preferences: some patients strongly prefer oral administration and accept the stricter dosing schedule of tablets, while others find once-daily injections with a tiny needle (32G, 4mm) more convenient than remembering three daily capsules with Orlistat or fasting requirements with oral semaglutide.

Hidden Costs and Long-Term Treatment Expenses

When evaluating saxenda pills alternatives, consider the full treatment duration. Clinical guidelines recommend GLP-1 treatments like Saxenda injections or Wegovy® tablets for at least 3-6 months to achieve meaningful weight loss, with many patients continuing for 12+ months [6]. Orlistat-based treatments are often used for similar durations. At Cured Pharmacy, we guarantee the lowest UK prices with no hidden consultation fees — our UK-registered clinical team provides free assessments under 3 minutes, and you only pay the medication price shown.

Clinical Effectiveness: How Saxenda Pills Alternatives Compare

Patients searching for saxenda pills want to know if oral alternatives work as well as injections. The STEP 8 trial directly compared injectable semaglutide 2.4mg (Wegovy injection) against injectable liraglutide 3.0mg (Saxenda), showing semaglutide produced significantly greater weight loss: 15.8% versus 6.4% at 68 weeks [7]. Oral semaglutide tablets, while requiring higher doses than injections due to lower bioavailability, demonstrated 15.1% average weight loss in the OASIS 1 trial — nearly matching injectable formulations.

Orlistat's mechanism differs entirely from the appetite suppression that saxenda pills would theoretically provide. By blocking fat absorption rather than affecting satiety hormones, Orlistat produces more modest results but with a well-established 20+ year safety profile in the UK. NICE guidance recognises Orlistat as appropriate first-line pharmacotherapy for patients with BMI ≥30 kg/m² (or ≥28 kg/m² with comorbidities), while GLP-1 treatments like Saxenda and Wegovy are typically reserved for those who haven't achieved sufficient weight loss with lifestyle changes alone [8].

Side Effects of Saxenda Pills Versus Oral Alternatives

Understanding side effects is crucial when comparing saxenda pills alternatives. GLP-1 treatments — whether injectable Saxenda or oral Wegovy® tablets — share similar gastrointestinal side effects because they work through the same mechanism. Nausea affects 40-50% of patients initially, with diarrhoea, constipation, and abdominal discomfort also common [1][3]. These effects typically diminish over 4-8 weeks as the body adapts, and gradual dose escalation minimises severity.

Orlistat causes distinctly different side effects related to its fat-blocking mechanism. Patients may experience oily stools, increased bowel movements, and faecal urgency, particularly when consuming high-fat meals [4]. While these effects can be socially inconvenient, they're generally not dangerous and can be managed by adhering to a reduced-fat diet (approximately 30% of calories from fat). Unlike GLP-1 treatments that rarely cause injection-site reactions with proper technique, Orlistat has no injection concerns since it's purely oral. Patients seeking saxenda pills specifically to avoid injections often find Orlistat's side effect profile more acceptable than the gastrointestinal effects of oral semaglutide.

Managing Side Effects with Oral Weight Loss Treatments

Our clinical team at Cured Pharmacy, led by superintendent pharmacist Tarun Kumar (GPhC 2233073), provides detailed guidance on minimising side effects with saxenda pills alternatives. For oral semaglutide, starting at low doses and escalating slowly over 8-16 weeks significantly reduces nausea. For Orlistat, distributing fat intake evenly across three meals and avoiding high-fat foods prevents the most troublesome gastrointestinal symptoms. All patients receive follow-up support and can contact our UK-registered pharmacists at (+44) 116 4646009 with any concerns during treatment.

How to Buy Saxenda Pills Alternatives Safely in the UK

Patients searching for saxenda pills online must be cautious of unregulated websites claiming to sell oral liraglutide or unlicensed formulations. At Cured Pharmacy (GPhC Registration Number 9012511), we supply only genuine UK-licensed medications: Wegovy® Oral Tablets manufactured by Novo Nordisk, and Orlistat products from established pharmaceutical companies. Every prescription treatment requires completion of a free online clinical assessment by our UK-registered prescribers, ensuring suitability and safety before dispensing.

The process takes under 3 minutes: complete the medical questionnaire on our website, receive a clinical decision typically within hours, and if approved, your medication is dispensed from our UK pharmacy with discreet next-day delivery. We never sell prescription medicines without proper clinical oversight, unlike unregulated online sources that may offer saxenda pills or similar products without prescriber involvement. Our transparent pricing shows costs upfront — from £48.00 for Orlistat-based treatments after your £20 discount with code Weightlossnew — with no hidden consultation fees or subscription traps common on other platforms.

Prescription Requirements and Clinical Assessment

All weight loss medications discussed as saxenda pills alternatives are prescription-only medicines (POMs) in the UK, regulated by the MHRA. Our clinical assessment evaluates your BMI, weight loss history, current medications, and relevant health conditions including cardiovascular risk factors, kidney function, and history of pancreatitis or thyroid disorders. GLP-1 treatments require particular caution in patients with diabetic retinopathy, and Orlistat is contraindicated in cholestasis or chronic malabsorption. This thorough evaluation ensures you receive the safest, most effective treatment for your individual circumstances — something no legitimate pharmacy can bypass when dispensing prescription medications.

Scientific References

1. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., ... & Wilding, J. P. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22. [accessed 24 August 2026]
2. Buckley, S. T., Bækdal, T. A., Vegge, A., Maarbjerg, S. J., Pyke, C., Ahnfelt-Rønne, J., ... & Knudsen, L. B. (2018). Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist. Science Translational Medicine, 10(467), eaar7047. [accessed 24 August 2026]
3. Knop, F. K., Aroda, V. R., do Vale, R. D., Holst-Hansen, T., Laursen, P. N., Rosenstock, J., ... & Wilding, J. P. (2023). Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet, 402(10403), 705-719. [accessed 24 August 2026]
4. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155-161. [accessed 24 August 2026]
5. Davies, M., Pieber, T. R., Hartoft-Nielsen, M. L., Hansen, O. K. H., Jabbour, S., & Rosenstock, J. (2017). Effect of oral semaglutide compared with placebo and subcutaneous semaglutide on glycemic control in patients with type 2 diabetes: a randomized clinical trial. JAMA, 318(15), 1460-1470. [accessed 24 August 2026]
6. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE guideline. [accessed 24 August 2026]
7. Rubino, D. M., Greenway, F. L., Khalid, U., O'Neil, P. M., Rosenstock, J., Sørrig, R., ... & Wilding, J. P. (2022). Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial. JAMA, 327(2), 138-150. [accessed 24 August 2026]
8. Medicines and Healthcare products Regulatory Agency. (2022). Public Assessment Report: Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg solution for injection in pre-filled pen. MHRA. [accessed 24 August 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 24 August 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 24 August 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 24 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.